{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T04:15:41Z","timestamp":1789186541332,"version":"build-2803163510"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009601","name":"Beijing Municipal Administration of Hospitals","doi-asserted-by":"publisher","award":["PX 2019015"],"award-info":[{"award-number":["PX 2019015"]}],"id":[{"id":"10.13039\/501100009601","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Beijing Municipal Health Committee Scientific Research Project","award":["Beijing 19-17"],"award-info":[{"award-number":["Beijing 19-17"]}]},{"name":"Beijing Hospitals Authority Youth Program","award":["QML20170401"],"award-info":[{"award-number":["QML20170401"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Orthop Surg Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      The 1-year mortality rate after femoral intertrochanteric fracture is higher than that of femoral neck fracture, which also belongs to hip fracture (Cui et al. in Arch Osteoporos 14(1):55, 2019). With the application of the concept of co-management model of orthopedics and geriatrics, the short-term and long-term mortality of all types of hip fractures has decreased (Van Heghe et al. in Calcif Tissue Int, 2021,\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/doi.org\/10.1007\/s00223-021-00913-5\">https:\/\/doi.org\/10.1007\/s00223-021-00913-5<\/jats:ext-link>\n                      ). However, the mortality of Chinese femoral intertrochanteric fracture patients under this model has not been reported in the literatures.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>This paper aims to study the risk factors of postoperative all-cause mortality in aged patients with femoral intertrochanteric fracture under the co-management model of orthopedics and geriatrics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>This is a single-center prospective cohort study based on the real world, under the co-management of orthopedics and geriatrics, 363 patients aged\u2009\u2265\u200965\u00a0years with femoral intertrochanteric fracture were enrolled and followed up for 2\u20133\u00a0years; 52 patients were lost to follow up. Age, gender, body mass index (BMI), history of comorbidities, hip Bone Mineral Density (BMD), fracture history, 25(OH)D level, hemoglobin level, anti-osteoporosis treatment were risk factors to be tested. Kaplan\u2013Meier survival curves and multivariate Cox proportional hazards models were constructed to analyze the impact of factors on all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>(1) Most of the dead patients were older (the mean age was 83.4\u00a0years, compared with 79.8\u00a0years for surviving patients), with more complications and without anti-osteoporosis medication; gender, pre-fracture history, BMI, total hip BMD, hemoglobin, 25(OH)D had no difference between the dead and the living patients. (2) Elderly patients with Intertrochanteric fracture can benefit from the early treatment of Zoledronic Acid (within 3\u00a0days after the operation).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Under the co-management of orthopedics and geriatrics, to Chinese patients with Femoral Intertrochanteric fracture, Doctors should pay more attention to their age and chronic disease, and give anti-osteoporosis treatment if allowed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13018-021-02874-9","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T05:03:12Z","timestamp":1639976592000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["All-cause mortality risk in aged femoral intertrochanteric fracture patients"],"prefix":"10.1186","volume":"16","author":[{"given":"Xin-ping","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-wen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-hui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-bao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xie-yuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"issue":"1","key":"2874_CR1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11657-019-0604-3","volume":"14","author":"Z Cui","year":"2019","unstructured":"Cui Z, Feng H, Meng X, Zhuang S, Liu Z, Ye K, et al. Age-specific 1-year mortality rates after hip fracture based on the populations in mainland China between the years 2000 and 2018: a systematic analysis. Arch Osteoporos. 2019;14(1):55.","journal-title":"Arch Osteoporos"},{"key":"2874_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-021-00913-5","author":"A Van Heghe","year":"2021","unstructured":"Van Heghe A, Mordant G, Dupont J, Dejaeger M, Laurent MR, Gielen E. Effects of orthogeriatric care models on outcomes of hip fracture patients: a systematic review and meta-analysis. Calcif Tissue Int. 2021. https:\/\/doi.org\/10.1007\/s00223-021-00913-5.","journal-title":"Calcif Tissue Int"},{"issue":"7","key":"2874_CR3","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00198-015-3093-2","volume":"26","author":"L Si","year":"2015","unstructured":"Si L, Winzenberg TM, Jiang Q, Chen M, Palmer AJ. Projection of osteoporosis-related fractures and costs in China: 2010\u20132050. Osteoporos Int. 2015;26(7):1929\u201337.","journal-title":"Osteoporos Int"},{"key":"2874_CR4","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijotn.2018.10.002","volume":"32","author":"C Biz","year":"2019","unstructured":"Biz C, Fantoni I, Crepaldi N, Zonta F, Buffon L, Corradin M, et al. Clinical practice and nursing management of pre-operative skin or skeletal traction for hip fractures in elderly patients: a cross-sectional three-institution study. Int J Orthop Trauma Nurs. 2019;32:32\u201340.","journal-title":"Int J Orthop Trauma Nurs"},{"key":"2874_CR5","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1007\/s00198-014-2799-x","volume":"25","author":"D Gibson-Smith","year":"2014","unstructured":"Gibson-Smith D, Klop C, Elders P, Welsing P, Schoor N, Leufkens H, et al. The risk of major and any (nonhip) fragility fracture after hip fracture in the United Kingdom: 2000\u20132010. Osteoporos Int. 2014;25:2555\u201363.","journal-title":"Osteoporos Int"},{"key":"2874_CR6","first-page":"937","volume":"10","author":"AS Nazrun","year":"2014","unstructured":"Nazrun AS, Tzar MN, Mokhtar SA, Mohamed IN. A systematic review of the outcomes of osteoporotic fracture patients after hospital discharge: morbidity, subsequent fractures, and mortality. Ther Clin Risk Manag. 2014;10:937\u201348.","journal-title":"Ther Clin Risk Manag"},{"key":"2874_CR7","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.2009.1462","volume":"302","author":"CA Brauer","year":"2009","unstructured":"Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB. Incidence and mortality of hip fractures in the United States. JAMA. 2009;302:1573\u20139.","journal-title":"JAMA"},{"key":"2874_CR8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.bone.2014.06.011","volume":"66","author":"C Klop","year":"2014","unstructured":"Klop C, Welsing PM, Cooper C, Harvey N, Elders P, Bijlsma J, et al. Mortality in British hip fracture patients, 2000\u20132010: a population-based retrospective cohort study. Bone. 2014;66:171\u20137.","journal-title":"Bone"},{"issue":"9","key":"2874_CR9","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1007\/s00198-021-05849-y","volume":"32","author":"XF Gong","year":"2021","unstructured":"Gong XF, Li XP, Zhang LX, Center JR, Bliuc D, Shi Y, et al. Current status and distribution of hip fractures among older adults in China. Osteoporos Int. 2021;32(9):1785\u201393.","journal-title":"Osteoporos Int"},{"issue":"5","key":"2874_CR10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jamda.2018.02.005","volume":"19","author":"SY Lee","year":"2018","unstructured":"Lee SY, Jung SH, Lee SU, Ha YC, Lim JY. Can bisphosphonates prevent recurrent fragility fractures? A systematic review and meta-analysis of randomized controlled trials. J Am Med Dir Assoc. 2018;19(5):384\u201390.","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"2874_CR11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jamda.2019.11.003","volume":"21","author":"S Abtahi","year":"2020","unstructured":"Abtahi S, Burden AM, Geusens P, van den Bergh JP, van Staa T, de Vries F. The association of oral bisphosphonate use with mortality risk following a major osteoporotic fracture in the United Kingdom: population-based cohort study. J Am Med Dir Assoc. 2020;21(6):811\u20136.","journal-title":"J Am Med Dir Assoc"},{"key":"2874_CR12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/agm2.12048","volume":"1","author":"W Li","year":"2018","unstructured":"Li W, Yang M. Fragility fracture network (FFN)-China successfully held forum to support FFN global call to action to improve the care of people with fragility fractures. Aging Med. 2018;1:280\u20131.","journal-title":"Aging Med"},{"key":"2874_CR13","doi-asserted-by":"crossref","unstructured":"Akesson K, Marsh D, Mitchell PJ, McLellan AR, Stenmark J, Pierroz DD, et al. IOF Fracture Working Group. Capture the fracture: a best practice framework and global campaign to break the fragility fracture cycle. Osteoporos Int. 2013;24(8):2135\u201352.","DOI":"10.1007\/s00198-013-2348-z"},{"key":"2874_CR14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1093\/bja\/aen236","volume":"101","author":"MJ Maxwell","year":"2008","unstructured":"Maxwell MJ, Moran CG, Moppett IK. Development and validation of a preoperative scoring system to predict 30 day mortality in patients undergoing hip fracture surgery. Br J Anaesth. 2008;101:511\u20137.","journal-title":"Br J Anaesth"},{"issue":"5","key":"2874_CR15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/anae.13418","volume":"71","author":"TC Marufu","year":"2016","unstructured":"Marufu TC, White SM, Griffiths R, Moonesinghe SR, Moppett IK. Prediction of 30-day mortality after hip fracture surgery by the Nottingham hip fracture score and the surgical outcome risk tool. Anaesthesia. 2016;71(5):515\u201321.","journal-title":"Anaesthesia"},{"issue":"4","key":"2874_CR16","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1093\/bja\/aes187","volume":"109","author":"IK Moppett","year":"2012","unstructured":"Moppett IK, Parker M, Griffiths R, Bowers T, White SM, Moran CG. Nottingham hip fracture score: longitudinal and multi-centre assessment. Br J Anaesth. 2012;109(4):546\u201350.","journal-title":"Br J Anaesth"},{"key":"2874_CR17","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1172\/JCI110667","volume":"70","author":"BL Riggs","year":"1982","unstructured":"Riggs BL, Wahner HW, Seeman E, Offord KP, Dunn WL, Mazess RB, et al. Changes in bone mineral density of the proximal femur and spine with aging: differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest. 1982;70:716\u201323.","journal-title":"J Clin Invest"},{"key":"2874_CR18","doi-asserted-by":"crossref","unstructured":"Fox KM, Cummings SR, Williams E, Stone K; Study of Osteoporotic Fractures. Femoral neck and intertrochanteric fractures have different risk factors: a prospective study. Osteoporos Int. 2000;11(12):1018\u201323.","DOI":"10.1007\/s001980070022"},{"issue":"12","key":"2874_CR19","doi-asserted-by":"crossref","first-page":"M635","DOI":"10.1093\/gerona\/54.12.M635","volume":"54","author":"KM Fox","year":"1999","unstructured":"Fox KM, Magaziner J, Hebel JR, Kenzora JE, Kashner TM. Intertrochanteric versus femoral neck hip fractures: differential characteristics, treatment, and sequelae. J Gerontol A Biol Sci Med Sci. 1999;54(12):M635\u201340.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"1","key":"2874_CR20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3113\/JSOA.2018.0064","volume":"27","author":"NB Frisch","year":"2018","unstructured":"Frisch NB, Wessell N, Charters M, Greenstein A, Shaw J, Peterson E, Trent GS. Hip fracture mortality: differences between intertrochanteric and femoral neck fractures. J Surg Orthop Adv. 2018;27(1):64\u201371.","journal-title":"J Surg Orthop Adv"},{"key":"2874_CR21","doi-asserted-by":"crossref","unstructured":"Haentjens P, Autier P, Barette M, Venken K, Vanderschueren D, Boonen S; Hip Fracture Study Group. Survival and functional outcome according to hip fracture type: a one-year prospective cohort study in elderly women with an intertrochanteric or femoral neck fracture. Bone. 2007;41(6):958\u201364.","DOI":"10.1016\/j.bone.2007.08.026"},{"issue":"9","key":"2874_CR22","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1007\/s40520-021-01898-9","volume":"33","author":"A De Vincentis","year":"2021","unstructured":"De Vincentis A, Behr AU, Bellelli G, Bravi M, Castaldo A, Galluzzo L, et al. Orthogeriatric co-management for the care of older subjects with hip fracture: recommendations from an Italian intersociety consensus. Aging Clin Exp Res. 2021;33(9):2405\u201343.","journal-title":"Aging Clin Exp Res"},{"issue":"2","key":"2874_CR23","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/TA.0000000000002482","volume":"88","author":"K Mukherjee","year":"2020","unstructured":"Mukherjee K, Brooks SE, Barraco RD, Como JJ, Hwang F, Robinson BRH, Crandall ML. Elderly adults with isolated hip fractures orthogeriatric care versus standard care: a practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2020;88(2):266\u201378.","journal-title":"J Trauma Acute Care Surg"},{"key":"2874_CR24","unstructured":"Chinese Geriatrics Society Bone and Joint Association Orthopaedic Trauma Committee. Experts' concensus on diagnosis and management of geriatric hip fractures (2017). Chin J Orthop Trauma. 2017;19(11):921\u201327."},{"issue":"3","key":"2874_CR25","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/BOT.0b013e3182a5a045","volume":"28","author":"KV Grigoryan","year":"2014","unstructured":"Grigoryan KV, Javedan H, Rudolph JL. Orthogeriatric care models and outcomes in hip fracture patients: a systematic review and meta-analysis. J Orthop Trauma. 2014;28(3):49\u201355.","journal-title":"J Orthop Trauma"},{"issue":"11","key":"2874_CR26","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00402-013-1845-z","volume":"133","author":"R Biber","year":"2013","unstructured":"Biber R, Singler K, Curschmann-Horter M, Wicklein S, Sieber C, Bail HJ. Implementation of a co-managed geriatric fracture center reduces hospital stay and time-to-operation in elderly femoral neck fracture patients. Arch Orthop Trauma Surg. 2013;133(11):1527\u201331.","journal-title":"Arch Orthop Trauma Surg"},{"issue":"9978","key":"2874_CR27","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(14)62409-0","volume":"385","author":"A Prestmo","year":"2015","unstructured":"Prestmo A, Hagen G, Sletvold O, Helbostad JL, Thingstad P, Taraldsen K, et al. Comprehensive geriatric care for patients with hip fractures: a prospective, randomised, controlled trial. Lancet. 2015;385(9978):1623\u201333.","journal-title":"Lancet"},{"issue":"1","key":"2874_CR28","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bone.2013.05.015","volume":"56","author":"CB Wang","year":"2013","unstructured":"Wang CB, Lin CF, Liang WM, Cheng CF, Chang YJ, Wu HC, et al. Excess mortality after hip fracture among the elderly in Taiwan: a nationwide population-based cohort study. Bone. 2013;56(1):147\u201353.","journal-title":"Bone"},{"key":"2874_CR29","doi-asserted-by":"crossref","unstructured":"Ho-Le TP, Tran TS, Bliuc D, Pham HM, Frost SA, Center JR, Eisman JA, Nguyen TV. Epidemiological transition to mortality and refracture following an initial fracture. Elife. 2021;10:e61142.","DOI":"10.7554\/eLife.61142"},{"issue":"5","key":"2874_CR30","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.2009.50","volume":"301","author":"D Bliuc","year":"2009","unstructured":"Bliuc D, Nguyen ND, Milch VE, Nguyen TV, Eisman JA, Center JR. Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA. 2009;301(5):513\u201321.","journal-title":"JAMA"},{"key":"2874_CR31","doi-asserted-by":"crossref","unstructured":"Kannegaard PN, van der Mark S, Eiken P, Abrahamsen B. Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival. Age Ageing. 2010;39(2):203\u20139.","DOI":"10.1093\/ageing\/afp221"},{"issue":"11","key":"2874_CR32","doi-asserted-by":"crossref","first-page":"3251","DOI":"10.1007\/s00198-017-4169-y","volume":"28","author":"JH Koh","year":"2017","unstructured":"Koh JH, Myong JP, Yoo J, Lim YW, Lee J, Kwok SK, Park SH, Ju JH. Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years\u2019 experience in a single center. Osteoporos Int. 2017;28(11):3251\u20139.","journal-title":"Osteoporos Int"},{"issue":"8","key":"2874_CR33","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.1893","volume":"28","author":"L Gedmintas","year":"2013","unstructured":"Gedmintas L, Solomon DH, Kim SC. Bisphosphonates and risk of subtrochanteric, femoral shaft, and atypical femur fracture: a systematic review and meta analysis. J Bone Miner Res. 2013;28(8):1729\u201337.","journal-title":"J Bone Miner Res"},{"key":"2874_CR34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bone.2016.01.002","volume":"85","author":"JC Lo","year":"2016","unstructured":"Lo JC, Hui RL, Grimsrud CD, Chandra M, Neugebauer RS, Gonzalez JR, et al. The association of race\/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone. 2016;85:142\u20137.","journal-title":"Bone"},{"issue":"3899","key":"2874_CR35","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.165.3899.1262","volume":"165","author":"H Fleisch","year":"1969","unstructured":"Fleisch H, Russell RG, Francis MD. Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo. Science. 1969;165(3899):1262\u20134.","journal-title":"Science"},{"issue":"10","key":"2874_CR36","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1124\/dmd.108.021071","volume":"36","author":"HM Weiss","year":"2008","unstructured":"Weiss HM, Pfaar U, Schweitzer A, Wiegand H, Skerjanec A, Schran H. Biodistribution and plasma protein binding of zoledronic acid. Drug Metabol Dispos. 2008;36(10):2043\u20139.","journal-title":"Drug Metabol Dispos"},{"issue":"10","key":"2874_CR37","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1359\/jbmr.1997.12.10.1700","volume":"12","author":"SA Khan","year":"1997","unstructured":"Khan SA, Kanis JA, Vasikaran S, Kline WF, Matuszewski BK, McCloskey EV, et al. Elimination and biochemical responses to intravenous alendronate in postmenopausal osteoporosis. J Bone Miner Res. 1997;12(10):1700\u20137.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2874_CR38","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1056\/NEJMc062792","volume":"356","author":"SE Papapoulos","year":"2007","unstructured":"Papapoulos SE, Cremers SC. Prolonged bisphosphonate release after treatment in children. N Engl J Med. 2007;356(10):1075\u20136.","journal-title":"N Engl J Med"},{"issue":"2","key":"2874_CR39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00774-020-01140-y","volume":"39","author":"XP Li","year":"2021","unstructured":"Li XP, Li XY, Yang MH, Zhu SW, Wu XB, Zhang P. Changes of bone turnover markers after elderly hip fracture surgery. J Bone Miner Metab. 2021;39(2):237\u201344.","journal-title":"J Bone Miner Metab"},{"issue":"3","key":"2874_CR40","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2009-0852","volume":"95","author":"MJ Bolland","year":"2010","unstructured":"Bolland MJ, Grey AB, Gamble GD, Reid IR. Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metab. 2010;95(3):1174\u201381.","journal-title":"J Clin Endocrinol Metab"},{"key":"2874_CR41","doi-asserted-by":"crossref","first-page":"115566","DOI":"10.1016\/j.bone.2020.115566","volume":"141","author":"JR Center","year":"2020","unstructured":"Center JR, Lyles KW, Bliuc D. Bisphosphonates and lifespan. Bone. 2020;141:115566.","journal-title":"Bone"},{"issue":"2","key":"2874_CR42","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1210\/jc.2008-2241","volume":"94","author":"A Grey","year":"2009","unstructured":"Grey A, Bolland MJ, Wattie D, Horne A, Gamble G, Reid IR. The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women. J Clin Endocrinol Metab. 2009;94(2):538\u201344.","journal-title":"J Clin Endocrinol Metab"},{"issue":"25","key":"2874_CR43","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1808082","volume":"379","author":"IR Reid","year":"2018","unstructured":"Reid IR, Horne AM, Mihov B, Stewart A, Garratt E, Wong S, et al. Fracture prevention with zoledronate in older women with osteopenia. N Engl J Med. 2018;379(25):2407\u201316.","journal-title":"N Engl J Med"},{"key":"2874_CR44","doi-asserted-by":"crossref","unstructured":"Reid IR, Black DM, Eastell R, Bucci-Rechtweg C, Su G, Hue TF, et al. HORIZON Pivotal Fracture Trial and HORIZON Recurrent Fracture Trial Steering Committees. Reduction in the risk of clinical fractures after a single dose of zoledronic Acid 5 milligrams. J Clin Endocrinol Metab. 2013;98(2):557\u201363.","DOI":"10.1210\/jc.2012-2868"},{"key":"2874_CR45","doi-asserted-by":"crossref","unstructured":"Lyles KW, Col\u00f3n-Emeric CS, Magaziner JS, Adachi JD, Pieper CF, Mautalen C, et al. HORIZON Recurrent Fracture Trial. Zoledronic acid and clinical fractures and mortality after hip fracture. N Engl J Med. 2007;357(18):1799\u2013809.","DOI":"10.1056\/NEJMoa074941"},{"issue":"7","key":"2874_CR46","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1359\/jbmr.090209","volume":"24","author":"EF Eriksen","year":"2009","unstructured":"Eriksen EF, Lyles KW, Col\u00f3n-Emeric CS, Pieper CF, Magaziner JS, Adachi JD, et al. Antifracture efficacy and reduction of mortality in relation to timing of the first dose of zoledronic acid after hip fracture. J Bone Miner Res. 2009;24(7):1308\u201313.","journal-title":"J Bone Miner Res"},{"issue":"10","key":"2874_CR47","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s00198-019-05097-1","volume":"30","author":"J Bergman","year":"2019","unstructured":"Bergman J, Nordstr\u00f6m A, Hommel A, Kivipelto M, Nordstr\u00f6m P. Bisphosphonates and mortality: confounding in observational studies? Osteoporos Int. 2019;30(10):1973\u201382.","journal-title":"Osteoporos Int"},{"issue":"5","key":"2874_CR48","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/os.12517","volume":"11","author":"PW Wang","year":"2019","unstructured":"Wang PW, Li YZ, Zhuang HF, Yu HM, Cai SQ, Xu H, et al. Anti-osteoporosis medications associated with decreased mortality after hip fracture. Orthop Surg. 2019;11(5):777\u201383.","journal-title":"Orthop Surg"},{"issue":"1","key":"2874_CR49","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00198-015-3415-4","volume":"27","author":"W Brozek","year":"2016","unstructured":"Brozek W, Reichardt B, Zwerina J, Dimai HP, Klaushofer K, Zwettler E. Antiresorptive therapy and risk of mortality and refracture in osteoporosis-related hip fracture: a nationwide study. Osteoporos Int. 2016;27(1):387\u201396.","journal-title":"Osteoporos Int"},{"issue":"1","key":"2874_CR50","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00198-012-2024-8","volume":"24","author":"L Bondo","year":"2013","unstructured":"Bondo L, Eiken P, Abrahamsen B. Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients a nationwide register based open cohort study. Osteoporos Int. 2013;24(1):245\u201352.","journal-title":"Osteoporos Int"},{"issue":"6","key":"2874_CR51","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/joim.12678","volume":"282","author":"KF Axelsson","year":"2017","unstructured":"Axelsson KF, Wallander M, Johansson H, Lundh D, Lorentzon M. Hip fracture risk and safety with alendronate treatment in the oldest-old. J Intern Med. 2017;282(6):546\u201359.","journal-title":"J Intern Med"},{"issue":"3","key":"2874_CR52","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00198-010-1411-2","volume":"22","author":"LA Beaupre","year":"2011","unstructured":"Beaupre LA, Morrish DW, Hanley DA, Maksymowych WP, Bell NR, Juby AG, Majumdar SR. Oral bisphosphonates are associated with reduced mortality after hip fracture. Osteoporos Int. 2011;22(3):983\u201391.","journal-title":"Osteoporos Int"},{"key":"2874_CR53","doi-asserted-by":"crossref","unstructured":"Van Geel TACM, Bliuc D, Geusens PPM, Center JR, Dinant GJ, Tran T, et al. Reduced mortality and subsequent fracture risk associated with oral bisphosphonate recommendation in a fracture liaison service setting: a prospective cohort study. PLoS ONE. 2018;13(6):e0198006.","DOI":"10.1371\/journal.pone.0198006"}],"container-title":["Journal of Orthopaedic Surgery and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-021-02874-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13018-021-02874-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13018-021-02874-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T05:30:03Z","timestamp":1639978203000},"score":1,"resource":{"primary":{"URL":"https:\/\/josr-online.biomedcentral.com\/articles\/10.1186\/s13018-021-02874-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2874"],"URL":"https:\/\/doi.org\/10.1186\/s13018-021-02874-9","relation":{},"ISSN":["1749-799X"],"issn-type":[{"value":"1749-799X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"2 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Board of Beijing Jishuitan Hospital approved the study with the approval number of 201907-09.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"727"}}